1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Cellvax Therapeutics Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer FK-PC101, Standard of Care (SOC) - Prostate Cancer (Adenocarcinoma), Prostate CA | Phase 2 | Recruiting | Cellvax Therapeutics Inc | 100 | 2024-10-14 | 2024-10-21 |
Adenocarcinoma (1) · Prostatic Neoplasms (1)
Standard of Care (1)
United States (1)